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Background
The description of Schizophrenia and Bipolar Disorder as disparate clinical entities arose 
from a Kraepelinian distinction in the time period from the late 19th to early 20th century, 
which soon became known as the Kraepelinian Dichotomy. Over the years, many studies 
were conducted to gain further insight as to whether or not this distinction continued to hold 
true. The increase in interest in the study and impact of the phenomenology associated with 
psychiatric illness in the 1980’s led to the Kraepelinian Dichotomy being operationalized in 
the third revision of the Diagnostic and Statistical Manual of Psychiatric Disorders (DSM) 
(1). The Kraepelinian Dichotomy continues to be engrained in psychiatric practice and yet 
the age-old debate as to whether or not the dichotomy “holds true” persists. The current 
article reviews the existent neuroimaging literature on this topic in an effort to illustrate the 
neurobiological evidence that either supports or refutes this dichotomy. The article 
concludes with related recommendations as to suggested revisions to the current categorical 
nosology of the DSM IV-TR.
Despite Kraepelin’s initial conceptualization, he later acknowledged that Schizophrenia and 
Bipolar Disorder may indeed share some overlapping clinical features. Kraepelin began to 
appreciate that it was not individual symptoms that would distinguish Schizophrenia and 
Bipolar Disorder, but rather the pattern of their presentation that would provide these clinical 
delineations. While Kraepelin believed Schizophrenia to be associated with a gradual and 
progressive cognitive and functional decline, he believed manic-depression to be more 
representative of a course of intermittent decline in functioning interwoven with periods of 
return to baseline and full recovery of illness. Kraepelin found, through his studies of 
6To whom correspondence should be addressed: Alan R. Prossin, M.D., Comprehensive Depression Center, Department of Psychiatry, 
University of Michigan Medical School, 4250 Plymouth Rd., Suite# 2409, Ann Arbor, MI 48105, Telephone: 734-389-9397, FAX: 
734-936-2690, prossin@med.umich.edu. 
Financial Disclosures
The authors declare no potential conflict of interest.
HHS Public Access
Author manuscript
Psychiatr Ann. Author manuscript; available in PMC 2018 October 25.
Published in final edited form as:
Psychiatr Ann. 2010 March ; 40(3): 154–159. doi:10.3928/00485713-20100303-09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
families, that indeed what he termed Dementia Praecox (Bleuler later renamed this as 
Schizophrenia) and Manic Depression (later differentiated into various mood disorders 
including Bipolar illness and Depression)(2, 3) appeared to be inherited traits based on the 
similarities in course and outcome among generations within families.
Some clinicians of the era debated the idea of a mutually exclusive or dichotomous 
characterization of these debilitating illnesses. In a more integrative fashion, Kasanin 
introduced the term Schizoaffective Disorder with its inherent overlap between mood and 
psychotic symptoms. Some clinicians and researchers continue to argue that given the 
significant clinical overlap, a certain degree of shared biological (and likely associated 
genetic) predisposition is likely present. Indeed, Kraepelin’s discussions on the ability of 
these disorders to “breed true” emphasized the inherited nature of these syndromes, 
providing evidence of his foresight of the need to identify biological features of these 
illnesses to gain a mechanistic understanding of their similarities and differentiation.
Despite some early questions and debate as to the degree of overlap between these clinical 
illnesses, the increase in genetic and family studies over the past two to three decades has 
resulted in the re-ignition of this age-old debate. The extent of clinical overlap between 
Schizophrenia and Bipolar Disorder that were identified in research studies support the 
overlap that was readily apparent from clinical practice. Some of the factors involved in this 
overlap include epidemiological factors (i.e. age of onset, sex distributions, and prevalence) 
and clinical presentations (i.e. Schizophrenia with superimposed mood symptoms and 
psychotic presentations of Bipolar Disorder). Until recently, however, there has been limited 
research involving neurobiological phenotypes of this overlap.
We set out to review the literature that explores this issue by reviewing studies that 
specifically compared and contrasted the various imaging findings between Schizophrenia 
and Bipolar Disorder. While the bulk of the neuroimaging literature comparing and 
contrasting the findings amongst these two clinical paradigms relates to volume comparisons 
derived from anatomical studies (i.e. post mortem anatomy, structural magnetic resonance 
imaging (MRI)), the evolution of functional neuroimaging research paradigms has resulted 
in a slow but gradual increase in the numbers and quality of studies that compare and 
contrast the brain function between these two debilitating illnesses.
Methods
An extensive literature review of original research articles comparing neuroimaging findings 
in Schizophrenia and Bipolar Disorder was conducted using PubMed. In all articles 
reviewed here, diagnoses were to be made based on the DSM version that was current at the 
time of article submission. A post-mortem anatomical study was also included to represent 
earlier work and as a reference to compare more recent neuroimaging findings against. The 
literature search was further narrowed by including only those original research articles 
whose paradigms were based on the following neuro-imaging techniques: structural 
Magnetic Resonance Imaging (MRI), Diffusion Tensor Imaging (DTI), Magnetic Resonance 
Spectroscopy (MRS), Positron Emission Tomography (PET), and functional Magnetic 
Resonance Imaging (fMRI). Of the approximately 80 original research articles obtained 
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form our intensive search (“Brain Imaging Bipolar Schizophrenia”; MRI Bipolar 
Schizophrenia”, PET Bipolar Schizophrenia”, “fMRI Bipolar Schizophrenia”, “Functional 
Bipolar Schizophrenia”) the results were narrowed down to approximately 20 articles based 
on methodological soundness and quality of research. The results were further organized 
categorically based on imaging modality and then further subdivided based on regional 
findings. These findings are outlined in the attached table (Table 1) under the following 
categories: Post-Mortem, MRI, MRS, DTI, PET, and fMRI. This was not intended to be a 
thorough review of neuroimaging for each individual disorder, but rather, an outline of 
findings from studies that specifically compared Schizophrenia and Bipolar Disorder and 
which possibly had related these findings to those of healthy controls.
Additionally, to further investigate whether the Kraeplinian Dichotomy and the associated 
neuroimaging findings “hold true,” some studies focusing on genetic studies have been 
included. Where possible, comparisons of neuronal circuitry from a systems based approach 
to neuroimaging has been highlighted. However, despite these efforts, the bulk of the studies 
comparing these two illnesses involved anatomical comparisons from structural MRI.
Results
The majority of articles identified involved comparing and contrasting the brain structure in 
individuals with Schizophrenia and Bipolar Disorder with that of healthy controls (Table 1). 
While there has been some work done in PET imaging (Table 1), investigating the 
differences in the various receptor systems specifically across these diagnostic boundaries, 
this volume of this research is not great – perhaps due to the ethical concerns of withholding 
treatment from this clinically unstable group of individuals.
A post-mortem study (4) investigating diagnostic comparisons of neuronal somal size within 
the layers of the insular cortex, has determined that schizophrenic subjects have a reduction 
in neuronal somal size within a particular layer of the insula as compared to bipolar subjects.
The structural MRI studies reviewed (Table 1) show consistent evidence that in 
Schizophrenia there is a reduction in hippocampal volumes and an increase in ventricular 
size compared to patients with Bipolar Disorder. However, there is less consistency 
regarding frontal and subcortical changes in terms of replication of findings, presence or 
absence of lateralization, and clinical association.
In an MRS investigation (5) (Table 1), although no difference in metabolites between 
diagnostic categories was detected, Bipolar subjects on lithium treatment evidenced elevated 
NAA/PCr-Cr in the basal ganglia region as compared to healthy controls, an effect that could 
be confounded by the effects of medication.
Of the fMRI studies reviewed (Table 1), a common theme emerged indicating activation 
differences in the prefrontal cortex between subjects with Bipolar Disorder and subjects with 
Schizophrenia. These differences do not appear to be limited to psychotic presentations of 
mood episodes and include subjects with Bipolar Disorder Type I in general. Of particular 
interest is that these differences occurred across a variety of tasks including emotional 
prosody, sentence completion, and verbal fluency. It should be noted that one study 
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identified a link between the effect of genotype for neuroreglin-1 and activation under a 
verbal fluency task, with effect of genotype being associated with greater deactivation in the 
left precuneus across diagnostic boundaries (Schizophrenia, Bipolar Disorder, and healthy 
controls). This study additionally identified an association between effect of genotype and 
activation that appeared to separate out with clinical categories (inferior frontal gyrus in 
subjects with high risk for Schizophrenia; posterior orbital gyrus in subjects with high risk 
for Bipolar Disorder).
We identified and selected two PET studies that specifically compared the neurobiology of 
Schizophrenia and Bipolar Disorder I (Table 1). One of these studies directly measured 
particular receptor or transporter binding potentials, and the second study used PET to 
measure cerebral blood flow. Zubieta et al found differences in the concentration of vesicular 
monoamine transporters (VMAT2), as measured with the radiotracer [11C]DTBZ, reflecting 
aminergic synaptic density, between schizophrenic and bipolar subjects in the thalamus, as 
well as between Bipolar Disorder and healthy subjects (6)(7). In another study that 
investigated the diagnostic differences in blood flow in the superior temporal cortex, no 
effects of diagnosis were found (8).
There has been little work done to date examining the differences in measures of white 
matter tracks and neuronal connectivity between Schizophrenia and Bipolar Disorder. 
However, one recent study investigating connectivity with diffusion tensor imaging found 
that although patient groups and controls had differences in fractional anisotropy compared 
to healthy controls, these differences did not hold for comparisons across the diagnostic 
categories of Schizophrenia and Bipolar Disorder (9) (Table 1).
Conclusion
The neurobiological/neuropsychological domains affected in Bipolar Disorder have been 
identified as being more widespread and more closely related to Schizophrenia than 
originally expected. However, the degree of severity of these changes is disparate, with 
Schizophrenia resulting in a typically more severe neuropsychological deterioration than that 
of Bipolar Disorder. The convergence that is seen within endophenotypes (i.e. neuroimaging 
data) associated with certain phenotypic domains (i.e. psychosis) suggests the presence of a 
dimensional pattern of illness. However, the existence of overlap with Schizophrenia appears 
more consistent in psychotic forms of Bipolar Disorder as compared to non-psychotic 
Bipolar Disorder. Although on comparing respective measures of connectivity, fractional 
anisotropy was indeed found to be similar across diagnostic boundaries in certain brain 
regions (i.e. anterior limb of internal capsule, anterior thalamic radiation, and uncinate 
fasciculus) and with FA differences noted between either patient group and healthy controls.
Attempts to separate out these psychiatric pathologies by spectroscopic measures have not 
proven beneficial. Specifically, evidence of changes in the concentrations of various cellular 
markers (i.e. Choline, Inositol & NAA/PCr-Cr) in the basal ganglia has been observed only 
in bipolar patients on lithium treatment whereas concentrations in both the basal ganglia and 
occipital cortex were found to be similar between Schizophrenia and Bipolar Disorder. In 
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addition, these similarities overlapped with those of healthy controls, suggesting that this 
measure may not be helpful in differentiating these psychopathologies from normalcy.
Additionally, other associations (i.e. left amygdala volume associated with verbal memory) 
highlight the vast differences between these illnesses and in so doing provide more support 
to the categorical nosology present in the current version of the DSM. Indeed, just as many 
non-overlapping findings are evident from our review of neuroimaging in Schizophrenia and 
Bipolar Disorder. Most notable are the volumetric differences in the ventricles, 
hippocampus, and amygdala between Schizophrenia and Bipolar Disorder that have been 
widely reproduced. However, if these changes were to be represented on a continuum, we 
wouldn’t expect such disparate association with neuropsychological functioning as has been 
pointed out by Kilgore et al. who were unable to find differences in amygdala volume, but 
did find that left amygdala volume in bipolars was positively correlated to verbal memory, 
while conversely in Schizophrenia, it was negatively correlated to memory (10).
The PET findings illustrate the idea of partial overlap and co-existing heterogeneity of these 
two psychiatric illnesses with Diagnostic effects being associated with vesicular monoamine 
transporter (VMAT2) binding in both the thalamus (Bipolar Disorder having greater binding 
than Schizophrenia or healthy controls) and the Ventral Brainstem (similar binding in 
Bipolar Disorder and Schizophrenia, both of which are greater than that in healthy controls). 
Other research showed no diagnostic difference in regional cerebral blood flow 
measurements.
The results of the fMRI studies yield similar results - some supporting the dichotomy and 
others supporting a dimensional explanation. There is evidence to show that bipolar and 
schizophrenic subjects differentially activated portions of their insula and prefrontal cortex 
during sentence completion and differential activation of the prefrontal cortex during verbal 
fluency tasks. Additionally, tasks of emotional prosody appeared to highlight both 
differential activation and similarities in activation between Schizophrenia and Bipolar 
Disorder. Despite the fact that recent studies have suggested neuroregulin-1 as a 
susceptibility gene for Schizophrenia and Bipolar Disorder, the results outlined have shown 
regions of deactivation associated with the neuroregulin-1 gene that appear to be common to 
Bipolar Disorder, Schizophrenia, and healthy controls (left precuneus). Additionally, an 
interaction between genotype and regional activation in the prefrontal cortex is present in 
both Bipolar Disorder and Schizophrenia, but these regions of activation are disparate, 
outlining the possibility that despite a possible genetic similarity across these diagnostic 
paradigms, the functional implication of this genetic susceptibility appears to be somewhat 
disparate.
In summary, the available neuroimaging findings that have been reviewed support the 
presence of both an overlap and a distinction between the circuitry that appears to be 
involved in the pathophysiology of Schizophrenia and Bipolar Disorder. At present, the 
majority of available data is limited to neuroanatomical measures of both grey matter and 
white matter, with a recent trend towards an increase in functional studies. The findings of 
anatomical and functional overlap would be helpful in informing genetic association studies 
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in this area. Additionally, further longitudinal neuroimaging incorporated into family studies 
would likely provide more evidence to support these hypotheses.
The above findings neither refute nor prove the Kraepelinian Dichotomy, but certainly 
provide evidence for an overlap between neurobiological factors underlying both disorders. 
The results of this review validate the need for the further investigation of biomarkers that 
will assist in the sub-classification of those psychiatric illnesses whose symptom clusters lie 
along the spectrum of mood and psychotic dimensions. These discoveries will likely 
highlight the complexity of disordered neurobiology, yielding a greater prominence to 
biologically driven diagnostic and treatment approaches in chronic neuropsychiatric 
illnesses. The key question that emerges is not surrounding the validity of the Kraepelinian 
Dichotomy, but rather how do we move forward in our transition away from descriptive 
clinical classifications and towards a diagnostic system that is aligned with the complex 
neurobiological underpinnings of these disorders, and more akin to clusters of biological 
disparities and similarities.
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